About

We love our portfolio companies.

You’ll love working for one of them.

177
Companies
2,622
Jobs
Volastra Therapeutics
Volastra Therapeutics
volastratx.com

Locations

New York, NY, USA

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

Series A

founded in

2019

Volastra Therapeutics is a New York-based drug discovery and therapeutics company pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN), cancer’s most targetable vulnerability. Founded by Lewis Cantley, Ph.D., Olivier Elemento, Ph.D., and Samuel Bakhoum, M.D., Ph.D., Volastra is advancing a novel synthetic lethal and immune activating pipeline. Leading its portfolio, Volastra has two KIF18A inhibitors in Phase 1 clinical trials for cancers with high levels of chromosomal instability.

Something looks off?
Open jobs at Volastra Therapeutics

On-site & Remote